Zacks Investment Research on MSN
Wall Street analysts think Syndax (SNDX) could surge 70.38%: Read this before placing a bet
Syndax Pharmaceuticals (SNDX) closed the last trading session at $22.89, gaining 23.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Definium Therapeutics, Inc.
The mean of analysts' price targets for FTC Solar (FTCI) points to a 94.1% upside in the stock. While this highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results